Bigbear Pharmaceutical·Medication Guide

• The Role of Avatrombopag in Modern Hematology: An Overview for Patients

  Avatrombopag is an oral medication used to treat chronic liver disease or chemotherapy-related thrombocytopenia. Common side effects include headache,···【Read More】

  Update: 2026-02-24Source: Haiou HealthViews: 75

• Exploring Financial Assistance for Avatrombopag: Grants, Copay Cards, and Payment Plans

  The price of avatrombopag varies considerably, typically ranging from several hundred to several thousand RMB per box. The specific price depends prim···【Read More】

  Update: 2026-02-24Source: Haiou HealthViews: 74

• Is Avatrombopag Covered by Insurance? A Guide to Prior Authorization and Coverage

  Avatrombopag is a prescription drug used to treat thrombocytopenia or immune thrombocytopenia associated with chronic liver disease. The specific cost···【Read More】

  Update: 2026-02-24Source: Haiou HealthViews: 74

• Does Insurance Cover Eltrombopag? Cost & Savings Guide

  The price of Eltrombopag (Generic Name: Eltrombopag Olamine Tablets) varies depending on specifications, origin, and purchasing channels. Actual costs···【Read More】

  Update: 2026-02-13Source: Haiou HealthViews: 72

• Has Eltrombopag Been Launched?

  Eltrombopag is an oral thrombopoietin receptor agonist that provides an effective treatment option for thrombocytopenia caused by various factors.Has ···【Read More】

  Update: 2026-02-13Source: Haiou HealthViews: 73

• Novartis Promacta Becomes the First First-Line Drug for SAA

  The immunotherapy drug Promacta (eltrombopag) has recently received FDA approval to expand its label. It is now indicated for use in combination with ···【Read More】

  Update: 2026-02-13Source: Haiou HealthViews: 73

• FDA Approves Promacta as First-Line Treatment for SAA

  Severe Aplastic Anemia (SAA) is a serious and rare blood disorder that can be fatal if not treated promptly; current initial treatments have shown lim···【Read More】

  Update: 2026-02-13Source: Haiou HealthViews: 73

• Selpercatinib Indications: FDA-Approved RET Fusion-Positive Cancers

  Selpercatinib is a treatment option recommended by the National Comprehensive Cancer Network (NCCN) for certain patients with RET-positive metastatic ···【Read More】

  Update: 2026-02-12Source: Haiou HealthViews: 73

• What side effects can selpercatinib cause?

  If you experience side effects, your doctor may change your dose, temporarily stop, or permanently discontinue treatment with selpercatinib. Do not ch···【Read More】

  Update: 2026-02-12Source: Haiou HealthViews: 74